- Home
- IBRX vs IAC Comparison
IBRX vs IAC Comparison
Compare IBRX & IAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- IAC
- Stock Information
- Founded
- IBRX 2014
- IAC N/A
- Country
- IBRX United States
- IAC United States
- Employees
- IBRX N/A
- IAC N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- IAC Computer Software: Programming Data Processing
- Sector
- IBRX Health Care
- IAC Technology
- Exchange
- IBRX Nasdaq
- IAC Nasdaq
- Market Cap
- IBRX 2.3B
- IAC 2.7B
- IPO Year
- IBRX N/A
- IAC 1992
- Fundamental
- Price
- IBRX $2.26
- IAC $32.57
- Analyst Decision
- IBRX Strong Buy
- IAC Strong Buy
- Analyst Count
- IBRX 6
- IAC 14
- Target Price
- IBRX $9.83
- IAC $49.21
- AVG Volume (30 Days)
- IBRX 9.4M
- IAC 1.0M
- Earning Date
- IBRX 11-10-2025
- IAC 11-03-2025
- Dividend Yield
- IBRX N/A
- IAC N/A
- EPS Growth
- IBRX N/A
- IAC N/A
- EPS
- IBRX N/A
- IAC N/A
- Revenue
- IBRX $56,600,000.00
- IAC $3,705,967,000.00
- Revenue This Year
- IBRX $629.94
- IAC N/A
- Revenue Next Year
- IBRX $109.91
- IAC $0.08
- P/E Ratio
- IBRX N/A
- IAC N/A
- Revenue Growth
- IBRX 4227.22
- IAC 8.11
- 52 Week Low
- IBRX $1.83
- IAC $31.30
- 52 Week High
- IBRX $5.88
- IAC $45.25
- Technical
- Relative Strength Index (RSI)
- IBRX 39.09
- IAC 42.06
- Support Level
- IBRX $2.30
- IAC $31.30
- Resistance Level
- IBRX $2.67
- IAC $34.33
- Average True Range (ATR)
- IBRX 0.12
- IAC 0.74
- MACD
- IBRX -0.02
- IAC -0.03
- Stochastic Oscillator
- IBRX 1.19
- IAC 41.75
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About IAC IAC Inc.
IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.